Cibc World Markets Corp Dexcom Inc Transaction History

Cibc World Markets Corp

$13.5 Billion
Q3 2024

A detailed history of Cibc World Markets Corp transactions in Dexcom Inc stock. As of the latest transaction made, Cibc World Markets Corp holds 62,977 shares of DXCM stock, worth $4.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

62,977

Previous 79,370 20.65%

Holding current value

$4.8 Million

Previous $9 Million 53.1%

% of portfolio

0.03%

Previous 0.06%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$64.0 - $116.06 $1.05 Million - $1.9 Million	-16,393 Reduced 20.65%	62,977 $4.22 Million
Q2 2024 Aug 12, 2024	BUY	$110.31 - $140.45 $1.69 Million - $2.15 Million	15,280 Added 23.84%	79,370 $9 Million
Q1 2024 May 13, 2024	SELL	$114.22 - $140.1 $4.7 Million - $5.76 Million	-41,142 Reduced 39.1%	64,090 $8.89 Million
Q4 2023 Feb 13, 2024	BUY	$75.49 - $124.16 $2.96 Million - $4.87 Million	39,202 Added 59.37%	105,232 $13.1 Million
Q3 2023 Nov 13, 2023	SELL	$86.06 - $137.93 $1.02 Million - $1.63 Million	-11,853 Reduced 15.22%	66,030 $6.16 Million
Q2 2023 Aug 04, 2023	BUY	$112.47 - $130.98 $6.04 Million - $7.03 Million	53,706 Added 222.14%	77,883 $10 Million
Q1 2023 May 11, 2023	SELL	$104.0 - $122.92 $2.69 Million - $3.17 Million	-25,827 Reduced 51.65%	24,177 $2.81 Million
Q4 2022 Feb 09, 2023	BUY	$84.98 - $122.67 $3.74 Million - $5.4 Million	44,047 Added 739.42%	50,004 $5.66 Million
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $3.31 Million - $4.08 Million	-43,312 Reduced 87.91%	5,957 $480,000
Q2 2022 Aug 12, 2022	BUY	$67.99 - $132.89 $1.8 Million - $3.52 Million	26,521 Added 116.59%	49,269 $3.67 Million
Q1 2022 May 13, 2022	BUY	$94.08 - $130.2 $220,899 - $305,709	2,348 Added 11.51%	22,748 $11.6 Million
Q4 2021 Feb 11, 2022	SELL	$129.87 - $162.82 $681,038 - $853,828	-5,244 Reduced 20.45%	20,400 $11 Million
Q3 2021 Nov 12, 2021	BUY	$106.71 - $143.18 $1.91 Million - $2.56 Million	17,882 Added 230.38%	25,644 $14 Million
Q2 2021 Aug 10, 2021	SELL	$80.99 - $107.93 $412,320 - $549,471	-5,091 Reduced 39.61%	7,762 $3.31 Million
Q1 2021 May 07, 2021	SELL	$84.79 - $104.74 $1.14 Million - $1.41 Million	-13,426 Reduced 51.09%	12,853 $4.62 Million
Q4 2020 Feb 12, 2021	BUY	$78.0 - $104.5 $734,526 - $984,076	9,417 Added 55.85%	26,279 $9.72 Million
Q3 2020 Nov 12, 2020	BUY	$95.51 - $112.95 $172,968 - $204,552	1,811 Added 12.03%	16,862 $6.95 Million
Q2 2020 Aug 12, 2020	BUY	$62.68 - $105.34 $943,396 - $1.59 Million	15,051 New	15,051 $6.1 Million
Q1 2019 May 14, 2019	SELL	$28.07 - $38.18 $3.41 Million - $4.64 Million	-121,600 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$26.99 - $37.37 $3.28 Million - $4.54 Million	121,600 New	121,600 $14.6 Million

Others Institutions Holding DXCM

# of Institutions

1,013

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Markets Corp with notifications on news.

Account

Cibc World Markets Corp Dexcom Inc Transaction History